
Health
Alzheimer's drug Leqembi: Anvisa approves use in Brazil
The approval of the Alzheimer's drug Leqembi by the National Health Surveillance Agency (Anvisa) marks one of the most significant advances in the treatment of Alzheimer's disease in Brazil in recent years.








